The role of advanced glycation end products in progression and complications of diabetes

By S. Goh, M. Cooper. 2008

1,022 citations recorded by the source corpus.

Subfields: Cell Biology, Clinical Biochemistry, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/5bc73bf41ed24c4a59f50afe51a3183056e2d998

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Mariyam Khalid
2. R. Seiça
3. C. Sena
4. A. Adem
5. A. Pereira
6. G. Petroianu

Citations in the corpus

• Endothelial dysfunction - a major mediator of diabetic vascular disease. (2013, background): “11) [191,192], specifically directed to reduce inflammation [193,232] and restore the ox/redox balance in the endothelium may represent promising strategies to ameliorate vascular function in diabetic state.”
• Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives (2022, background): “Due to this covalent cross-link formation, the biologically active proteins and enzymes are deactivated [8,16], become resistant to proteolytic digestion [17,18], provide catalytic sites for ROS formation [19], lead to pro-inflammatory events [6], alter intracellular signaling and contribute to seve”